4//SEC Filing
Wood Gavin 4
Accession 0001104659-22-004154
CIK 0001621227other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:03 PM ET
Size
8.6 KB
Accession
0001104659-22-004154
Insider Transaction Report
Form 4
Wood Gavin
Chief Financial Officer
Transactions
- Award
Option to purchase Ordinary Shares
2022-01-12+314,256→ 314,256 totalExercise: $0.00Exp: 2032-01-12→ Ordinary Shares (314,256 underlying) - Award
Option to purchase Ordinary Shares
2022-01-12+1,407,072→ 1,407,072 totalExercise: $0.60Exp: 2032-01-12→ Ordinary Shares (1,407,072 underlying)
Footnotes (4)
- [F1]The exercise price was converted from GBP0.44 based on an exchange rate of U.S.$ 1.362272 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F2]Exercisable as to 351,768 Ordinary Shares on January 12, 2023 and will be exercisable as to the remainder in monthly installments of 29,310 Ordinary Shares on the twelfth of each month from February 12, 2023 through December 12, 2025 and 29,454 Ordinary Shares on January 12, 2026.
- [F3]The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$ 1.362272 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F4]Exercisable as to 78,564 Ordinary Shares on January 12, 2023 and will be exercisable as to the remainder in annual installments of 78,564 Ordinary Shares on the twelfth of each January from January 12, 2024 through January 12, 2026.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001577539
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 9:03 PM ET
- Size
- 8.6 KB